治疗恶性肿瘤的中药处方分析  

An analysis of TCM prescription on malignant tumor

作　　者：江华[1] 徐学刚[1] 

机构地区：[1]江苏省启东市人民医院,江苏启东226200

出　　处：《中医临床研究》2018年第1期16-18,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究临床治疗恶性肿瘤的中药处方的应用情况。方法:选择我院2015年1-9月收治的30例中药治疗的恶性肿瘤患者,分析30例患者中药处方中各类中药的合理使用情况及治疗效果。结果:恶性肿瘤患者中药处方中以清热解毒药、补益药和利水渗湿药最为常用,常见的中药饮片有党参、白花蛇舌草、茯苓等药物;30例患者经中药治疗后2年生存率为86.67%,治疗总有效率为53.33%,不良反应发生率为6.67%,治疗后生活能力BI指标评分为(72.06±8.53)分,显著高于治疗前(P<0.05)。结论:中药处方以中医辨证施治理论为指导,在恶性肿瘤患者的治疗中根据患者症候及病情给予清热解毒、活血化瘀、益气补肾等疗法,从整体上改善患者机体免疫能力,抑制并杀死癌细胞生长,不良反应小,可作为恶性肿瘤患者的辅助治疗方法进行推广。Objective:To explore the application of TCM prescription in treating malignant tumor.Methods:30cases from January2015to September2015were selected.The rational use of various TCM medicines in30prescriptions was analyzed.Results:The prescriptions of Qingre Jiedu,Buyi and Lishui Shenshi were most commonly used in clinical.The common TCM medicine were Dangshen,Baihuashe She Cao,Fuling,and so on.The2-year survival rate of30patients after treatment was86.37%;the total efficiency was53.33%;the incidence of adverse reactions was6.67%.BI scores of living ability were(72.06±8.53)points,significantly higher than that before treatment(P<0.05).Conclusion:The TCM prescription is guided by the theory of TCM syndrome differentiation and treatment.According to the symptoms and conditions of patients with malignant tumor,the therapies of Qingre Jiedu,Huoxue Huayu,Yiqi Bushen and so on were given to improve the immunity,inhibit the growth of cancer cells,with fewer adverse reactions,and can be used as adjuvant therapy for malignant tumor patients.

关 键 词：中药处方 恶性肿瘤 合理用药 治疗效果 

分 类 号：R273[医药卫生—中西医结合]